$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| 6-K | 16 Mar 2017 |
| LYNPARZA PFS IN BRCA OVARIAN MAINTENANCE THERAPY | 15 Mar 2017 |
| FILING OF FORM 20-F WITH SEC | 08 Mar 2017 |
| ANNUAL FINANCIAL REPORT | 07 Mar 2017 |
| DIRECTORATE CHANGE | 06 Mar 2017 |
| ALLIANCE WITH SANOFI PASTEUR FOR MEDI8897 | 03 Mar 2017 |
| TOTAL VOTING RIGHTS | 01 Mar 2017 |
| FDA APPROVES ONCE DAILY QTERN FOR TYPE 2 DIABETES | 01 Mar 2017 |
| CHMP POSITIVE OPINION FOR ZS-9 IN HYPERKALAEMIA | 24 Feb 2017 |
| AZ LICENSES ZOLADEX TO TERSERA FOR THE US & CANADA | 21 Feb 2017 |
| LYNPARZA POSITIVE IN METASTATIC BRCA BREAST CANCER | 17 Feb 2017 |
| SILIQ (BRODALUMAB) APPROVED BY US FDA | 16 Feb 2017 |
| AZN: FY16 AND Q4 2016 RESULTS | 02 Feb 2017 |
| TOTAL VOTING RIGHTS | 01 Feb 2017 |
| SYMBICORT GRANTED PAEDIATRIC EXCLUSIVITY IN THE US | 26 Jan 2017 |
| AZ 1ST-LINE LUNG CANCER IMMUNO-ONCOLOGY PROGRAMME | 17 Jan 2017 |
| TOTAL VOTING RIGHTS | 03 Jan 2017 |
| AZ COMPLETES SALE OF ANTIBIOTICS BUSINESS | 23 Dec 2016 |
| DIRECTOR/PDMR SHAREHOLDING | 16 Dec 2016 |
| FDA ACCEPTS DURVALUMAB FOR BLA IN BLADDER CANCER | 09 Dec 2016 |
